vs

Side-by-side financial comparison of FLEXSTEEL INDUSTRIES INC (FLXS) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $115.1M, roughly 1.2× FLEXSTEEL INDUSTRIES INC). FLEXSTEEL INDUSTRIES INC runs the higher net margin — 17.7% vs -5.3%, a 23.0% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 1.0%). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 1.9%).

Flexsteel Industries Inc is a leading U.S.-headquartered furniture manufacturer that designs, produces and distributes a wide portfolio of upholstered residential, commercial, and hospitality furniture. It primarily operates across North American markets, serving end consumers, retail partners and corporate clients through its extensive distribution network.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

FLXS vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.2× larger
TOI
$142.0M
$115.1M
FLXS
Growing faster (revenue YoY)
TOI
TOI
+40.6% gap
TOI
41.6%
1.0%
FLXS
Higher net margin
FLXS
FLXS
23.0% more per $
FLXS
17.7%
-5.3%
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
1.9%
FLXS

Income Statement — Q1 FY2027 vs Q4 FY2025

Metric
FLXS
FLXS
TOI
TOI
Revenue
$115.1M
$142.0M
Net Profit
$20.4M
$-7.5M
Gross Margin
22.6%
Operating Margin
-4.9%
Net Margin
17.7%
-5.3%
Revenue YoY
1.0%
41.6%
Net Profit YoY
116.0%
43.0%
EPS (diluted)
$1.14
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLXS
FLXS
TOI
TOI
Q3 26
$115.1M
Q4 25
$118.2M
$142.0M
Q3 25
$110.4M
$136.6M
Q2 25
$114.6M
$119.8M
Q1 25
$114.0M
$104.4M
Q4 24
$108.5M
$100.3M
Q3 24
$104.0M
$99.9M
Q2 24
$110.8M
$98.6M
Net Profit
FLXS
FLXS
TOI
TOI
Q3 26
$20.4M
Q4 25
$6.6M
$-7.5M
Q3 25
$7.3M
$-16.5M
Q2 25
$10.7M
$-17.0M
Q1 25
$-3.7M
$-19.6M
Q4 24
$9.1M
$-13.2M
Q3 24
$4.1M
$-16.1M
Q2 24
$4.9M
$-15.5M
Gross Margin
FLXS
FLXS
TOI
TOI
Q3 26
22.6%
Q4 25
22.7%
Q3 25
23.5%
Q2 25
23.9%
Q1 25
22.2%
Q4 24
21.0%
Q3 24
21.5%
Q2 24
21.3%
Operating Margin
FLXS
FLXS
TOI
TOI
Q3 26
Q4 25
7.6%
-4.9%
Q3 25
8.1%
-5.9%
Q2 25
12.2%
-9.4%
Q1 25
-4.4%
-9.5%
Q4 24
10.7%
-11.9%
Q3 24
5.8%
-13.9%
Q2 24
6.9%
-16.6%
Net Margin
FLXS
FLXS
TOI
TOI
Q3 26
17.7%
Q4 25
5.6%
-5.3%
Q3 25
6.6%
-12.1%
Q2 25
9.3%
-14.2%
Q1 25
-3.3%
-18.8%
Q4 24
8.3%
-13.1%
Q3 24
4.0%
-16.1%
Q2 24
4.4%
-15.7%
EPS (diluted)
FLXS
FLXS
TOI
TOI
Q3 26
$1.14
Q4 25
$1.18
$-0.04
Q3 25
$1.31
$-0.14
Q2 25
$1.90
$-0.15
Q1 25
$-0.71
$-0.21
Q4 24
$1.62
$-0.14
Q3 24
$0.74
$-0.18
Q2 24
$0.87
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLXS
FLXS
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$57.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$185.3M
$-15.7M
Total Assets
$290.2M
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLXS
FLXS
TOI
TOI
Q3 26
$57.3M
Q4 25
$36.8M
Q3 25
$38.6M
Q2 25
$40.0M
Q1 25
$22.6M
Q4 24
$11.8M
Q3 24
$5.7M
Q2 24
$4.8M
$9.9M
Stockholders' Equity
FLXS
FLXS
TOI
TOI
Q3 26
$185.3M
Q4 25
$178.9M
$-15.7M
Q3 25
$172.2M
$-12.3M
Q2 25
$167.9M
$-9.0M
Q1 25
$158.1M
$5.1M
Q4 24
$161.9M
$3.6M
Q3 24
$154.7M
$15.5M
Q2 24
$150.4M
$29.2M
Total Assets
FLXS
FLXS
TOI
TOI
Q3 26
$290.2M
Q4 25
$290.2M
$164.7M
Q3 25
$281.5M
$163.6M
Q2 25
$282.5M
$159.8M
Q1 25
$266.1M
$164.0M
Q4 24
$271.5M
$172.7M
Q3 24
$268.7M
$179.2M
Q2 24
$274.5M
$179.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FLXS
FLXS
TOI
TOI
Operating Cash FlowLast quarter
$27.2M
$3.2M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
1.33×
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FLXS
FLXS
TOI
TOI
Q3 26
$27.2M
Q4 25
$1.0M
$3.2M
Q3 25
$4.1M
$-12.6M
Q2 25
$15.6M
$-10.2M
Q1 25
$12.3M
$-5.0M
Q4 24
$6.7M
$4.2M
Q3 24
$2.4M
$819.0K
Q2 24
$7.5M
$-15.7M
Free Cash Flow
FLXS
FLXS
TOI
TOI
Q3 26
Q4 25
$-735.0K
$2.2M
Q3 25
$2.8M
$-13.2M
Q2 25
$15.1M
$-11.4M
Q1 25
$10.9M
$-5.3M
Q4 24
$5.8M
$2.4M
Q3 24
$2.0M
$417.0K
Q2 24
$7.1M
$-17.5M
FCF Margin
FLXS
FLXS
TOI
TOI
Q3 26
Q4 25
-0.6%
1.5%
Q3 25
2.5%
-9.7%
Q2 25
13.1%
-9.5%
Q1 25
9.6%
-5.1%
Q4 24
5.3%
2.4%
Q3 24
1.9%
0.4%
Q2 24
6.4%
-17.7%
Capex Intensity
FLXS
FLXS
TOI
TOI
Q3 26
Q4 25
1.5%
0.7%
Q3 25
1.2%
0.4%
Q2 25
0.5%
1.0%
Q1 25
1.2%
0.3%
Q4 24
0.8%
1.8%
Q3 24
0.4%
0.4%
Q2 24
0.4%
1.9%
Cash Conversion
FLXS
FLXS
TOI
TOI
Q3 26
1.33×
Q4 25
0.15×
Q3 25
0.56×
Q2 25
1.46×
Q1 25
Q4 24
0.74×
Q3 24
0.58×
Q2 24
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FLXS
FLXS

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons